|
- Elucid | Visualize Lesion-level Plaque Composition
Developed in partnership with world-renowned cardiovascular pathologists, ground truth histology serves as the basis for training Elucid’s powerful algorithm to objectively quantify vessel structure and plaque composition
- Elucid Receives U. S. 510 (k) Clearance of PlaqueIQ™ Image Analysis . . .
Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary plaque buildup), the root cause of cardiovascular disease
- News - Elucid
BOSTON – March 3, 2025 – Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has added several senior members to its clinical and commercial teams
- Elucid Raises $80 Million in Series C Round Led by Elevage Medical . . .
Elucid is a Boston-based medical technology company dedicated to bringing precision patient care, as currently practiced in oncology, to cardiology Its AI-powered imaging analysis software is designed to understand the root cause of cardiovascular disease deeply
- Elucid Announces Favorable Medicare Coverage of AI Coronary Plaque . . .
Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary plaque buildup), the root cause of cardiovascular disease
- Elucid Adds Clinical and Commercial Leadership Ahead of PlaqueIQ . . .
Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary plaque buildup), the root cause of cardiovascular disease
- Elucid Names Kelly Huang as CEO
Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to help physicians better understand the root cause of cardiovascular disease
- Elucid Presents Data Demonstrating Its AI Software Can Uniquely . . .
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease
|
|
|